Jacob Eli Gunn Glanville is an American computational immunoengineer and businessperson. He is co-founder and chief executive officer of the start-up company Distributed Bio[1] and its spin-out, Centivax.[2] [3] Glanville was featured in the documentary series .[4] Glanville was born in The Dalles, Oregon and raised in Guatemala to American expatriate parents.[5] His mother is an artist and his father an inn keeper. In 2007, Glanville graduated from University of California, Berkeley where he studied genetics, Genomics, and Development in the Molecular and Cellular Biology program and conducted research in the Glenys Thomsom HLA population genetics laboratory and Kimmen Sjolander Berkeley Phylogenomics group. In 2008, he joined Pfizer and was promoted to staff scientist four years later. In 2012, Glanville founded Distributed Bio and became the first Computational and Systems Immunology Ph.D. candidate at Stanford University. He completed his doctorate in 2017. His doctoral advisors were Scott D. Boyd and Mark M. Davis. Glanville's dissertation was titled Reading the adaptive receptor repertoires.[6] Microbiologist Sarah Ives is his research co-lead at Distributed Bio on the influenza project featured in .
Jacob Glanville was interviewed on Checkpoint, Radio New Zealand 31 March 2020